Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
40.17
-0.37 (-0.91%)
At close: Feb 11, 2026, 4:00 PM EST
40.00
-0.17 (-0.42%)
After-hours: Feb 11, 2026, 7:27 PM EST
Liquidia Market Cap
Liquidia has a market cap or net worth of $3.49 billion as of February 11, 2026. Its market cap has increased by 194.71% in one year.
Market Cap
3.49B
Enterprise Value
3.54B
1-Year Change
194.71%
Ranking
Category
Stock Price
$40.17
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $3.49B, an increase of 1,982.92%. That is a compound annual growth rate of 49.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.53B | 17.54% |
| Dec 31, 2025 | 3.00B | 201.46% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Terns Pharmaceuticals | 4.13B |
| CG Oncology | 4.12B |
| Arcellx | 3.98B |
| NewAmsterdam Pharma Company | 3.97B |
| ACADIA Pharmaceuticals | 3.93B |
| ADMA Biologics | 3.90B |
| Erasca | 3.72B |
| Ligand Pharmaceuticals | 3.68B |